391 related articles for article (PubMed ID: 34390751)
1. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.
Skrzypek A; Matysiak J; Niewiadomy A; Bajda M; Szymański P
Eur J Med Chem; 2013 Apr; 62():311-9. PubMed ID: 23376249
[TBL] [Abstract][Full Text] [Related]
3. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Molecular Docking of New Bis-Thiazolidinone-Based Chalcone Analogs as Effective Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Hussain R; Rahim F; Rehman W; Taha M; Khan S; Zaman K; Adnan Ali Shah S; Wadood A; Imran S; Abdellatif MH
Chem Biodivers; 2022 Oct; 19(10):e202200323. PubMed ID: 35997224
[TBL] [Abstract][Full Text] [Related]
5. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
6. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
7. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
8. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
Rehman TU; Khan IU; Ashraf M; Tarazi H; Riaz S; Yar M
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220522
[TBL] [Abstract][Full Text] [Related]
9. New indole derivatives as multitarget anti-Alzheimer's agents: synthesis, biological evaluation and molecular dynamics.
Azmy EM; Nassar IF; Hagras M; Fawzy IM; Hegazy M; Mokhtar MM; Yehia AM; Ismail NS; Lashin WH
Future Med Chem; 2023 Mar; 15(6):473-495. PubMed ID: 37125532
[No Abstract] [Full Text] [Related]
10. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
12. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of
Alcorn KN; Oberhauser IA; Politeski MD; Eckroat TJ
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286935. PubMed ID: 38059272
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase.
Khan S; Iqbal S; Taha M; Rahim F; Shah M; Ullah H; Bahadur A; Alrbyawi H; Dera AA; Alahmdi MI; Pashameah RA; Alzahrani E; Farouk AE
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364195
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds.
Skrzypek A; Matysiak J; Karpińska MM; Niewiadomy A
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):816-23. PubMed ID: 22630076
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
17. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
[TBL] [Abstract][Full Text] [Related]
18. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
[TBL] [Abstract][Full Text] [Related]
19. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
20. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
